Evotec, Sanofi deal

The companies partnered to develop and commercialize a stem cell-derived beta cell replacement therapy for diabetes. The partners said the therapy could potentially reduce or eliminate the need for insulin injections. The companies will also use beta cells for high throughput screening to identify beta cell modulating small molecules or biologics. ...